Needham Investment Management LLC G1 Therapeutics, Inc. Transaction History

Needham Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $60,480 - $201,420	-54,000 Reduced 23.08%	180,000 $549,000
Q1 2023 May 12, 2023	BUY	$2.57 - $8.16 $128,499 - $408,000	50,000 Added 27.17%	234,000 $627,000
Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $259,500 - $675,000	50,000 Added 37.31%	184,000 $999,000
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $105,040 - $221,260	-26,000 Reduced 16.25%	134,000 $662,000
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $342,000 - $495,900	45,000 Added 39.13%	160,000 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $269,240 - $428,505	26,500 Added 29.94%	115,000 $1.17 Million
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $802,760 - $1.37 Million	61,000 Added 221.82%	88,500 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $146,775 - $197,400	7,500 Added 37.5%	27,500 $603,000
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $35,160 - $65,180	2,000 Added 11.11%	20,000 $481,000
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $197,820 - $367,200	18,000 New	18,000 $324,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Needham Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Needham Investment Management LLC with notifications on news.